Our 2-year retrospective analysis revealed that high baseline CRP levels were related with increased T2DM risk, and the impact was substantially greater when combined with other high inflammatory marker levels, particularly with IL-6. This evidence concerns the gene IL6 and type 2 diabetes mellitus.